Your Genetic Test Didn't Find a Mutation. Why Your Family History Still Guides Your Care.

By Amanda Shrewsbury, MS, CGC

When someone undergoes genetic testing for hereditary cancer risk due to their family history and the result comes back with no mutation found, it is natural to feel relief and assume the risk has been ruled out. However, an uninformative negative result does not erase the risk one may have based on their family history of cancer.

This is one of the most misunderstood moments in hereditary cancer care. A genetic test that does not identify a pathogenic variant can feel like a clean bill of health, and sometimes it partly is. But when there is a meaningful family history of cancer that's not explained by a mutation, the result often does not tell the whole story, and the family history itself remains a medically important guide for screening and prevention.

This post is for anyone who has been tested because of their family history and received a result that did not provide a clear answer, whether that was a negative result with no mutation found or a variant of uncertain significance. It explains what those results mean, why family history still matters, and what screening and prevention can look like even when genetic testing does not pinpoint a cause.

First, what makes a negative or VUS result "uninformative"?

Not every negative result means the same thing, and the distinction matters.

An uninformative negative happens when a person is tested, often because of a family history of cancer, and no pathogenic variant is found, and no specific variant had previously been identified in the family. The result is called uninformative because it does not explain the cancer in the family. It did not find an answer, but it also did not rule hereditary risk out. This is different from a true negative, which is when a specific pathogenic variant is known to run in a family and a person tests negative for that exact variant. A true negative is much more definitive. An uninformative negative simply means testing did not find a cause, which is not the same as proving there isn't one.

This is also why testing a family member who has actually had cancer, when one is available and willing, is so valuable. If a hereditary cause is present in a family, it is most likely to be detectable in a relative who developed cancer, so testing that person first gives the best chance of identifying a variant if one exists. When only an unaffected relative is tested, a negative result is much harder to interpret, because it cannot distinguish between a family that has no detectable mutation and a family that has a mutation the tested person simply did not inherit. For this reason, when a relative with a cancer diagnosis or history is willing and able to be tested, that testing often provides the clearest and most useful information for the whole family.

A variant of uncertain significance (VUS) is a genetic change that has been found but does not yet have enough scientific evidence to be classified as either harmful or harmless. Because its meaning is unknown, a VUS cannot be used to guide medical care, so a person with a VUS is functionally in a similar position: the genetic test did not provide an actionable answer. We explain this result type in depth in our post on variants of uncertain significance.

It is worth knowing that a VUS may not stay uncertain forever. As scientific evidence grows, most VUS results are eventually reclassified, and the large majority are reclassified as benign rather than pathogenic. When a laboratory reclassifies a variant, it issues an amended report to the ordering provider. Because notifying patients of a reclassification is understood to be a shared responsibility among the laboratory, the ordering provider, and the patient, rather than a guaranteed automatic process, it is important to keep your contact information current with both the testing laboratory and your genetic counselor, and to periodically follow up over time. That way, if a VUS is reclassified in a way that changes your care, the update is more likely to reach you.

Why family history still matters, even without a mutation

Current genetic testing cannot detect every hereditary cause of cancer. Science has not yet identified every gene involved in cancer risk, and some inherited risk is driven by combinations of factors that testing cannot capture. This means a family can carry genuinely elevated risk that a genetic test is simply not yet able to pinpoint.

Because of this, family history is treated as its own risk factor in medical guidelines, independent of genetic test results. A strong family history can change screening recommendations on its own, regardless of whether a mutation is ever found. The sections below walk through what that looks like for several common cancers.

Family history of breast cancer

When there is a family history of breast cancer but no mutation is identified, a person's risk can be estimated using a validated risk model, such as the Tyrer-Cuzick model, which incorporates family history along with other personal factors to calculate an estimated lifetime risk of breast cancer.

This estimate can directly change screening. If a person's estimated lifetime risk reaches approximately 20 percent or higher, guidelines from organizations including the National Comprehensive Cancer Network and the American Cancer Society recommend considering annual breast MRI in addition to annual mammography, beginning either at age 40 or 10 years before the earliest breast cancer diagnosis in the family, whichever comes first. In other words, a family history of breast cancer, even with an uninformative genetic result, can lead to enhanced and potentially earlier screening that a person would not otherwise receive. Our post on BRCA1 and BRCA2 covers the hereditary side of breast cancer risk in more detail.

Family history of colorectal cancer

Colorectal cancer is one of the clearest examples of family history driving screening independent of genetic results.

A person with a first-degree relative (a parent, sibling, or child) who had colorectal cancer is generally recommended to begin colonoscopy at age 40, or 10 years before the age at which their youngest affected relative was diagnosed, whichever comes first, and to repeat colonoscopy every 5 years rather than following the standard 10 year interval. This is meaningfully earlier and more frequent than average-risk screening, and it applies based on family history alone.

Family history of colon polyps matters too. If a relative had a significant number of colon polyps or a known polyposis condition, earlier or more frequent colonoscopy may be recommended. Our post on Lynch syndrome covers a hereditary form of colorectal cancer risk, and our post on the cancers that can be hereditary puts colorectal cancer in the wider context.

Family history of ovarian cancer

Ovarian cancer is a more nuanced case, because there is currently no effective screening test for it. Unlike breast or colorectal cancer, there is no equivalent of a mammogram or colonoscopy that reliably detects ovarian cancer early in the general population.

This changes the conversation for someone with a family history of ovarian cancer but no identified mutation. Rather than a routine screening test, the focus is on individualized risk assessment and, in some situations, a discussion of risk-reducing options with a care team. What is appropriate depends heavily on the specifics of the family history and personal circumstances, which is exactly the kind of situation a genetic counselor can help evaluate. Our post on the cancers that can be hereditary discusses ovarian cancer risk further.

Family history of pancreatic cancer

Pancreatic cancer offers perhaps the clearest illustration of this entire post's point. Even when no pathogenic variant is identified, a person can still qualify for pancreatic cancer surveillance based on family history alone.

This is because of a concept called a familial pancreatic cancer kindred, generally defined as a family with at least two first-degree relatives who have had pancreatic cancer (or a first-degree relative who in turn has another first-degree relative with pancreatic cancer history). If a person is part of a familial pancreatic cancer kindred, they may be offered pancreatic cancer screening even if their genetic testing came back with no mutation found. The family pattern itself is enough to warrant surveillance. For example, if a person's father and paternal uncle both had pancreatic cancer, that family history qualifies as a familial pancreatic cancer kindred, and screening should be offered regardless of genetic testing results. Our post on pancreatic cancer and genetic testing goes deeper into this.

The through-line: family history is its own risk factor

Across all of these cancers, the pattern is the same. An uninformative negative or an uncertain genetic result does not erase the risk that a family history represents, and guideline-based screening and prevention pathways exist precisely for this situation. A person can qualify for earlier colonoscopy, enhanced breast screening, a risk-reduction discussion, or pancreatic surveillance based on family history alone, with no identified mutation at all.

The genetic test is one tool. Family history is another, and it remains one of the most powerful tools available for guiding care.

What to do if this is your situation

If you were tested because of your family history and received a negative result with no mutation found, or a variant of uncertain significance, the most useful thing you can do is make sure your family history still gets the attention it deserves.

A genetic counselor can help interpret an uninformative result, assess your risk based on your family history, and work with your care team to coordinate appropriate screening and prevention. A genetic counselor can also help you understand what to watch for over time, including the possibility that a VUS could be reclassified in the future.

A few resources from our blog that may help:

A genetic test that does not find a mutation is not the end of the conversation, because your family history remains one of the most important tools we have for guiding screening and prevention, whatever your genetic results happen to show.

---

References

Facing Our Risk of Cancer Empowered (FORCE). (2025). Understanding genetic test results. https://www.facingourrisk.org/

National Comprehensive Cancer Network. (2026). NCCN clinical practice guidelines in oncology: Genetic/familial high-risk assessment — Breast, ovarian, and pancreatic (Version 3.2026). https://www.nccn.org/

National Comprehensive Cancer Network. (2026). NCCN clinical practice guidelines in oncology: Colorectal cancer screening (Version 1.2026). https://www.nccn.org/

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–423.

---

This blog post is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician, genetic counselor, or other qualified healthcare provider with any questions you may have regarding a medical condition or your individual health needs.